Cited by 317Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental DisordersCRISPR and Genetic Engineering

In vivo Perturb-Seq reveals neuronal and glial abnormalities associated with autism risk genes

Open access
Jin, Xin, Simmons, Sean K., Guo, Amy, Shetty, Ashwin S., Ko, Michelle, Nguyen, Lan, Jokhi, Vahbiz, Robinson, Elise +8 more·2020·Science

Published version of a preprint

Abstract

An in vivo analysis of autism risk genes: CRISPR targeting in vivo, especially in mammals, can be difficult and time consuming when attempting to determine the effects of a single gene. However, such studies may be required to identify pathological gene variants with effects in specific cells along a developmental trajectory. To study the function of genes implicated in autism spectrum disorders (ASDs), Jin et al. applied a gene-editing and single-cell–sequencing system, Perturb-Seq, to knock out 35 ASD candidate genes in multiple mice embryos (see the Perspective by Treutlein and Camp). This method identified networks of gene expression in neuronal and glial cells that suggest new functions in ASD-related genes. Science , this issue p. eaaz6063 ; see also p. 1038

Integrity signals

Registry

Crossref · 10.1126/science.aaz6063

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 49 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    Loss of Dyrk1a significantly reduced the proportion of microglia/macrophages.

    “Only loss of Dyrk1a had a significant effect on cell type composition, increasing the proportion of oligodendrocytes and reducing the proportion of microglia/macrophages [FDR-corrected P<0.05 using Poisson regression (18)] (Figs. 1D and S5).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [18] Haber AL, A single-cell survey of the small intestinal epithelium. Nature 551, 333– 339 (2017). 29144463 PMC6022292 source

      Not checked in the free run.

  • Findingown data

    ASD/ND risk gene perturbations had a very modest effect on the presence and proportions of the five major cell types relative to the negative control.

    “ASD/ND risk gene perturbations had a very modest effect on the presence and proportions of these five major cell types relative to the negative control (targeting the GFP gene).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Multiple ASD/ND loss-of-function risk gene mutations rarely co-occur in patients.
  • Findingown data

    Lentiviral vector expression was detected in cortical microglia, indicated by BFP and perturbation barcode expression, across multiple individual experiments.

    “we detected lentiviral vector expression in cortical microglia, indicated by the presence of BFP as well as perturbation barcode expression, across multiple individual experiments (fig. S4E–F).”
    Quote in the paperNot a substantial claim
  • Findingown data

    50% of cells in the five major cell classes had barcodes for a single gene.

    “and 50% had barcodes for a single gene (fig. S4A–C, 18,044 cells), reflecting the low multiplicity of infection (fig. S4D).”
    Quote in the paperSubstantial claim
  • Findingown data

    Perturb-Seq vectors were expressed across a variety of neuronal and glial cell types in the cortex at P7.

    “Both immunohistochemical analysis and scRNA-seq of BFP+ cells at P7 showed that the Perturb-Seq vectors were expressed across a variety of neuronal and glial cell types in the cortex (Figs. 1B–C and S3A–B).”
    Quote in the paperSubstantial claim
  • May combine two claims. 29
  • Classified as probably not a substantial claim. 22
  • The quote only partly states this claim. 1
  • May combine two claims.

    Findingcitation

    The selected ASD/ND risk genes are expressed in human brain tissue, with some highly expressed at embryonic stages and others from early postnatal to adult stages.

    “These ASD/ND risk genes are expressed in human brain tissue, as assessed by the BrainSpan bulk RNA-seq dataset (9); some are highly expressed at embryonic stages, and others highly expressed from early postnatal to adult stages (fig. S1B).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [9] Miller JA, Transcriptional landscape of the prenatal human brain. Nature 508, 199– 206 (2014). 24695229 PMC4105188

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    A median of 338 cells per perturbation was found.

    “We found a median of 338 cells per perturbation: after excluding perturbations with <70 perturbed cells, we retained 35 ASD/ND risk gene perturbations.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    SST in interneurons showed decreased expression in ASD patients and was significantly decreased across the panel of 35 ASD risk gene perturbations at FDR < 0.1.

    “From this analysis, we identified two genes, SST in interneurons and NRN1 in excitatory neurons, both of which showed decreased expression in ASD patients and were likewise significantly decreased in expression across our panel of perturbations (FDR < 0.1), albeit with different effect sizes (Fig. 4F, Table S10).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [31] Velmeshev D, Single-cell genomics identifies cell type-specific molecular changes in autism. Science 364, 685– 689 (2019). 31097668 PMC7678724 source

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    NRN1 in excitatory neurons showed decreased expression in ASD patients and was significantly decreased across the panel of 35 ASD risk gene perturbations at FDR < 0.1.

    “From this analysis, we identified two genes, SST in interneurons and NRN1 in excitatory neurons, both of which showed decreased expression in ASD patients and were likewise significantly decreased in expression across our panel of perturbations (FDR < 0.1), albeit with different effect sizes (Fig. 4F, Table S10).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [31] Velmeshev D, Single-cell genomics identifies cell type-specific molecular changes in autism. Science 364, 685– 689 (2019). 31097668 PMC7678724 source

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    Ank2-perturbed cells were present across all cell types and overall proportions of cells were not significantly changed.

    “Ank2-perturbed cells were present across all cell types and overall proportions of cells were not significantly changed (fig. S10B).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The expression of each module was largely conserved in all human datasets, with different modules showing distinct levels of conservation of expression in each dataset.

    “The expression of each module was largely conserved in all human datasets, with different modules showing distinct levels of conservation of expression in each dataset (Fig. 4A).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Module PN2 is associated with genes involved in neurite development and varied across cells in multiple projection neuron subclusters.

    “For example, module PN2 is associated with genes involved in neurite development and varied across cells in multiple projection neuron subclusters (fig. S6A).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The ODC1 module is highly expressed in cycling cells and oligodendrocyte precursor cells (OPC), and lowly expressed in committed oligodendrocyte progenitor cells (COP) and newly formed oligodendrocytes (NFOL).

    “The ODC1 module is highly expressed in cycling cells and oligodendrocyte precursor cells (OPC), and lowly expressed in committed oligodendrocyte progenitor cells (COP) and newly formed oligodendrocytes (NFOL), suggesting that this module is linked to oligodendrocyte maturation (Fig. 3A)”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingcitation

    The results showed that Chd8 modulates gene modules for oligodendrocyte differentiation and maturation, consistent with prior ChIP-Seq findings that CHD8 interacts directly with OPC maturation genes at perinatal stages.

    “Our results showed that Chd8 modulates gene modules for oligodendrocyte differentiation and maturation, consistent with previously reported ChIP-Seq results showing that CHD8 interacts directly with OPC maturation genes at perinatal stages of development (28, 43).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [28] Marie C, Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8. Proc Natl Acad Sci U S A, (2018). PMC6126750 30108144 source

      Not checked in the free run.

    • cites [43] Zhao C, Dual Requirement of CHD8 for Chromatin Landscape Establishment and Histone Methyltransferase Recruitment to Promote CNS Myelination and Repair. Dev Cell 45, 753– 768 e758 (2018). 29920279 PMC6063525 source

      Not checked in the free run.

  • May combine two claims. The quote only partly states this claim.

    Study design and conductown data

    The approach examined effects of each perturbation across a wide range of cell types from distinct brain regions under sparse labeling conditions where less than 0.1% of cortical cells were perturbed, making it highly unlikely that development of individual perturbed cells was affected by perturbed neighbors.

    “under sparse labeling conditions where less than 0.1% of cells in the cortex were perturbed, and thus development of individual perturbed cells is highly unlikely to be affected by perturbed neighbors (fig. S3A–C).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Focusing on gene modules instead of individual genes provides more statistical power to detect biologically meaningful perturbation effects with fewer cells and captures diversity within and across cell types.

    “As previous work has shown (11–13, 19), focusing on gene modules instead of individual genes provides more statistical power to detect biologically-meaningful perturbation effects using fewer cells than would be required for single gene-level analysis, and can capture diversity both within and across cell types.”
    Quote in the paperSubstantial claim0 of 4 sources checked
    • cites [11] Adamson B, A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response. Cell 167, 1867– 1882 e1821 (2016). 27984733 PMC5315571 source

      Not checked in the free run.

    • cites [12] Dixit A, Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens. Cell 167, 1853– 1866 e1817 (2016). 27984732 PMC5181115 source

      Not checked in the free run.

    • cites [13] Jaitin DA, Dissecting Immune Circuits by Linking CRISPR-Pooled Screens with Single-Cell RNA-Seq. Cell 167, 1883– 1896 e1815 (2016). 27984734 source

      Not checked in the free run.

    • cites [19] Duan B, Model-based understanding of single-cell CRISPR screening. Nat Commun 10, 2233 (2019). 31110232 PMC6527552 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    The control construct was included in the same pool as perturbation vectors to minimize batch-dependent variation.

    “To minimize batch-dependent variation, the control construct was included in the same pool as the perturbation vectors (fig. S3F).”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisecitation

    Trio-based whole-exome sequencing analyses have linked many de novo loss-of-function variants to risk of neurodevelopmental conditions, including autism spectrum disorder and neurodevelopmental delay.

    “analysis of trio-based whole-exome sequencing (WES) has implicated a large number of de novo loss-of-function variants contributing to risk of neurodevelopmental pathologies, including autism spectrum disorders and neurodevelopmental delay (ASD/ND) (4, 5).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [4] Satterstrom FK, Novel genes for autism implicate both excitatory and inhibitory cell lineages in risk. bioRxiv, 484113 (2018). source

      Not checked in the free run.

    • cites [5] Sanders SJ, De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237– 241 (2012). 22495306 PMC3667984 source

      Not checked in the free run.

  • May combine two claims.

    Study design and conductreasoning

    The multiplexed design tested cell-autonomous effects of all perturbations against a negative control construct targeting endogenous GFP in Rosa26, controlling for viral infection and other confounders.

    “This multiplexed experimental design allowed us to test the cell-autonomous effect of all perturbations against the effect of a negative control construct targeting the endogenous GFP in the Rosa26 locus, thus controlling for effects related to viral infection, among other confounders.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductown data

    Cell survival after FACS was 78%, and frameshift insertion/deletion was confirmed at 40-70% for each gRNA target among infected cells.

    “The cell survival rate after FACS was 78%, and we confirmed a 40–70% frameshift insertion/deletion for each gRNA target among the infected cells (fig. S3D–E).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    These ASD/ND genes could act in many different cell types and temporal frames, requiring scalable methods to test gene function across cell types and developmental events.

    “Thus, these ASD/ND genes could, in principle, act in many different cell types and temporal frames, requiring scalable methods to test gene function across a range of cell types and developmental events.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Few ASD/ND risk genes have been studied in animal or cellular models, leaving their developmental brain function poorly defined.
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    ASD/ND is a broad group of neurodevelopmental disorders with highly heterogeneous genetic contributions, including hundreds of highly penetrant de novo risk variant genes.

    “ASD/ND comprises a broad collection of neurodevelopmental disorders with highly heterogeneous genetic contributions, including hundreds of highly penetrant de novo risk variant genes (6).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [6] Chen JA, Penagarikano O, Belgard TG, Swarup V, Geschwind DH, The emerging picture of autism spectrum disorder: genetics and pathology. Annu Rev Pathol 10, 111– 144 (2015). 25621659 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    The GO-term approach is limited by the large number of tests performed and the limited number of GO terms relevant to developing cortex.

    “However, this approach is limited by the large number of tests performed (one test per GO term per cell type per perturbation, for a total of 510,265 tests), as well as the limited number of GO terms relevant to the developing cortex.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    The observed number of convergent modules across perturbations is likely an underestimation, and larger-scale experiments with more cells might reveal more.

    “It is likely that this represents an underestimation of the number of convergent modules across perturbations which might be revealed by larger-scale experiments using greater numbers of cells.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Ank2 encodes an ankyrin protein and is broadly expressed in excitatory and inhibitory neurons and glial cells in the brain.

    “Ank2 encodes an ankyrin protein and is expressed broadly in excitatory and inhibitory neurons as well as glial cells in the brain (23).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [23] Saunders A, Molecular Diversity and Specializations among the Cells of the Adult Mouse Brain. Cell 174, 1015– 1030 e1016 (2018). 30096299 PMC6447408 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Studies of Ank2 loss-of-function suggest it is involved in axonal morphology, connectivity, and calcium signaling in excitatory neurons.

    “Studies examining Ank2 loss-of-function suggest that it is involved in axonal morphology, connectivity, and calcium signaling in excitatory neurons (24–27).”
    Quote in the paperNot a substantial claim0 of 4 sources checked
    • cites [24] Scotland P, Zhou D, Benveniste H, Bennett V, Nervous system defects of AnkyrinB (−/−) mice suggest functional overlap between the cell adhesion molecule L1 and 440-kD AnkyrinB in premyelinated axons. J Cell Biol 143, 1305– 1315 (1998). 9832558 PMC2133070 source

      Not checked in the free run.

    • cites [25] Tuvia S, Buhusi M, Davis L, Reedy M, Bennett V, Ankyrin-B is required for intracellular sorting of structurally diverse Ca2+ homeostasis proteins. J Cell Biol 147, 995– 1008 (1999). 10579720 PMC2169334 source

      Not checked in the free run.

    • cites [26] Kline CF, Scott J, Curran J, Hund TJ, Mohler PJ, Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. J Biol Chem 289, 5285– 5295 (2014). 24394417 PMC3931084 source

      Not checked in the free run.

    • cites [27] Yang R, ANK2 autism mutation targeting giant ankyrin-B promotes axon branching and ectopic connectivity. Proc Natl Acad Sci U S A 116, 15262– 15271 (2019). 31285321 PMC6660793 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Ank2 encodes an ankyrin protein and is expressed broadly in excitatory and inhibitory neurons as well as glial cells in the brain.

    “Ank2 encodes an ankyrin protein and is expressed broadly in excitatory and inhibitory neurons as well as glial cells in the brain (23).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [23] Saunders A, Molecular Diversity and Specializations among the Cells of the Adult Mouse Brain. Cell 174, 1015– 1030 e1016 (2018). 30096299 PMC6447408 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Abnormal maturation of oligodendrocytes may be linked to long-lasting changes in neural wiring and brain function.

    “Oligodendrocytes modulate and consolidate neural circuit refinement, and abnormal maturation of oligodendrocytes may be linked to long-lasting changes in neural wiring and brain function (38).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [38] Bercury KK, Macklin WB, Dynamics and mechanisms of CNS myelination. Dev Cell 32, 447– 458 (2015). 25710531 PMC6715306 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Ank2 mutants show misregulation of intracellular calcium homeostasis and calcium channel expression in excitatory neurons.

    “Ank2 mutants showed misregulation of intracellular calcium homeostasis and calcium channel expression in excitatory neurons (25, 26), as well as increased axonal branching and ectopic connectivity (27).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [25] Tuvia S, Buhusi M, Davis L, Reedy M, Bennett V, Ankyrin-B is required for intracellular sorting of structurally diverse Ca2+ homeostasis proteins. J Cell Biol 147, 995– 1008 (1999). 10579720 PMC2169334 source

      Not checked in the free run.

    • cites [26] Kline CF, Scott J, Curran J, Hund TJ, Mohler PJ, Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. J Biol Chem 289, 5285– 5295 (2014). 24394417 PMC3931084 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Oligodendrocytes modulate and consolidate neural circuit refinement.

    “Oligodendrocytes modulate and consolidate neural circuit refinement, and abnormal maturation of oligodendrocytes may be linked to long-lasting changes in neural wiring and brain function (38).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [38] Bercury KK, Macklin WB, Dynamics and mechanisms of CNS myelination. Dev Cell 32, 447– 458 (2015). 25710531 PMC6715306 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Ankyrin homologs interact with ion channels in many neuronal types.

    “Ankyrin homologs interact with ion channels in many neuronal types, and Ankyrin-G has been shown to stabilize GABAergic synapses (37).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [37] Tseng WC, Jenkins PM, Tanaka M, Mooney R, Bennett V, Giant ankyrin-G stabilizes somatodendritic GABAergic synapses through opposing endocytosis of GABAA receptors. Proc Natl Acad Sci U S A 112, 1214– 1219 (2015). 25552561 PMC4313813 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Ank2 mutants show increased axonal branching and ectopic connectivity.

    “Ank2 mutants showed misregulation of intracellular calcium homeostasis and calcium channel expression in excitatory neurons (25, 26), as well as increased axonal branching and ectopic connectivity (27).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [27] Yang R, ANK2 autism mutation targeting giant ankyrin-B promotes axon branching and ectopic connectivity. Proc Natl Acad Sci U S A 116, 15262– 15271 (2019). 31285321 PMC6660793 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Ank2 loss-of-function causes hypoplasia of the corpus callosum and pyramidal tract and ultimately optic nerve degeneration, suggesting a requirement for Ank2 in maintaining premyelinated axons in excitatory neurons during early neurodevelopment.

    “Ank2 loss-of-function results in hypoplasia of the corpus callosum and pyramidal tract, and ultimately optic nerve degeneration (24), suggesting that it is required in the maintenance of premyelinated axons in excitatory neurons in early neurodevelopment.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [24] Scotland P, Zhou D, Benveniste H, Bennett V, Nervous system defects of AnkyrinB (−/−) mice suggest functional overlap between the cell adhesion molecule L1 and 440-kD AnkyrinB in premyelinated axons. J Cell Biol 143, 1305– 1315 (1998). 9832558 PMC2133070 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    The data indicate that a selected group of perturbations affected recurrent gene modules with cell-type specificity and point to convergent effects across diverse ASD/ND risk genes.

    “Collectively, the data indicate that a selected group of perturbations was able to affect recurrent gene modules with cell-type specificity, and point to some convergent effects across diverse ASD/ND risk genes.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Alternative approaches, including a linear mixed model-based approach and a permutation-based approach, were compared to evaluate the effects of modeling assumptions.

    “To evaluate the effects of these assumptions, we also compared alternative approaches, including a linear mixed model-based approach and a permutation-based approach (fig. S9, table S9).”
    Quote in the paperNot a substantial claim
    • The authors state this as an assumption: In the linear model, module expression in individual cells is independent after conditioning on experimental batch, and noise is normally distributed.
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given

    The in vivo Perturb-Seq method can be applied across diverse diseases and tissues.

    “In this work, we demonstrated the application of in vivo Perturb-Seq to ASD/ND risk genes in the developing brain; this method can be applied across diverse diseases and tissues.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The cellular and molecular substrates of ASD/ND are not yet defined.
    • Rests on an assumption: A large number of highly penetrant de novo risk genes implicated through human genetic studies provides an entry point to identify the cell types, developmental events, and mechanisms underlying ASD/ND.
    • Rests on an assumption: Scalable methods are required to define the function of risk-associated genes with cell-type specificity.
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    Cells were down-sampled so that no perturbation had more than twice the median number of cells over all perturbations, to prevent any single perturbation or batch from dominating the linear model.

    “To ensure that no single perturbation or batch dominated the linear model, we down-sampled the cells in each cell category such that no perturbation had more than two times the median number of cells over all perturbations.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Ankyrin-G stabilizes GABAergic synapses.

    “Ankyrin homologs interact with ion channels in many neuronal types, and Ankyrin-G has been shown to stabilize GABAergic synapses (37).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [37] Tseng WC, Jenkins PM, Tanaka M, Mooney R, Bennett V, Giant ankyrin-G stabilizes somatodendritic GABAergic synapses through opposing endocytosis of GABAA receptors. Proc Natl Acad Sci U S A 112, 1214– 1219 (2015). 25552561 PMC4313813 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The staining, imaging, and quantifications were double-blinded.

    “We double-blinded the staining, imaging, and quantifications.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Interpretationnone given

    Although the study focused on the perinatal neocortex, in vivo Perturb-Seq can be applied to study gene functions systematically across other tissues and developmental ages, revealing tissue-specific and broadly distributed functions.

    “Although we focused on the perinatal neocortex in this study, in vivo Perturb-Seq can be applied to study gene functions systematically across other tissues and developmental ages, to reveal tissue-specific as well as broadly-distributed gene functions.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The cellular and molecular substrates of ASD/ND are not yet defined.
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductown data

    Perturbation barcodes were identified by two complementary methods, and cells were retained only when the 10x and dial-out assignments agreed or when one method assigned a perturbation and the other did not assign any.

    “We then only kept cells for which either i) the assigned 10x and dialout perturbations agree or ii) the cell was assigned to a perturbation by one method but not assigned to any perturbation in the other.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [12] Dixit A, Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens. Cell 167, 1853– 1866 e1817 (2016). 27984732 PMC5181115 source

      Not checked in the free run.

  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductown data

    The human differential expression analysis used DESeq2 and corrected for sex and age.

    “DESeq2 v 1.20.0 (35) was then used to perform differential expression analysis between the ASD patients and the controls, correcting for sex and age.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [35] Love MI, Huber W, Anders S, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15, 550 (2014). 25516281 PMC4302049 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.

    Interpretationreasoning

    In vivo Perturb-Seq can enable discoveries of pathways and cell types affected in heterogeneous genetic pathologies, directing downstream studies and informing refined models for genetic disorders and mechanistic studies.

    “In vivo Perturb-Seq can enable discoveries of pathways and cell types affected in heterogenous genetic pathologies, directing downstream studies and informing the development of refined models for genetic disorders and mechanistic studies as we move from genetic variants to function.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The cellular and molecular substrates of ASD/ND are not yet defined.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The Wnt signaling pathway plays a crucial role in neuronal progenitor proliferation and differentiation in the forebrain.

    “One of the risk genes, Chd8, encodes a protein that binds directly to β-catenin to recruit histone proteins and negatively regulates the Wnt signaling pathway, which plays a crucial role in neuronal progenitor proliferation and differentiation in the forebrain (39–42).”
    Quote in the paperNot a substantial claim0 of 4 sources checked
    • cites [39] Platt RJ, Chd8 Mutation Leads to Autistic-like Behaviors and Impaired Striatal Circuits. Cell Rep 19, 335– 350 (2017). 28402856 PMC5455342 source

      Not checked in the free run.

    • cites [40] Katayama Y, CHD8 haploinsufficiency results in autistic-like phenotypes in mice. Nature 537, 675– 679 (2016). 27602517 source

      Not checked in the free run.

    • cites [41] Durak O, Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling. Nat Neurosci 19, 1477– 1488 (2016). 27694995 PMC5386887 source

      Not checked in the free run.

    • cites [42] Sakamoto I, A novel beta-catenin-binding protein inhibits beta-catenin-dependent Tcf activation and axis formation. J Biol Chem 275, 32871– 32878 (2000). 10921920 source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Study design and conductown data

    Linear regression testing the relationship between perturbations and WGCNA gene scores corrected for batch and number of genes.

    “Linear regression was used to test the relationship between perturbations and WGCNA gene scores, correcting for batch and number of genes.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationnone given

    The approach can uncover the impact of individual disease-associated genes, combinations of genes, and the overall set of processes they affect.

    “This approach can uncover both the impact of individual disease-associated genes and of combinations of genes and the overall set of processes that they affect.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The cellular and molecular substrates of ASD/ND are not yet defined.
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Chd8 encodes a protein that binds directly to β-catenin to recruit histone proteins and negatively regulates the Wnt signaling pathway.

    “One of the risk genes, Chd8, encodes a protein that binds directly to β-catenin to recruit histone proteins and negatively regulates the Wnt signaling pathway, which plays a crucial role in neuronal progenitor proliferation and differentiation in the forebrain (39–42).”
    Quote in the paperNot a substantial claim0 of 4 sources checked
    • cites [39] Platt RJ, Chd8 Mutation Leads to Autistic-like Behaviors and Impaired Striatal Circuits. Cell Rep 19, 335– 350 (2017). 28402856 PMC5455342 source

      Not checked in the free run.

    • cites [40] Katayama Y, CHD8 haploinsufficiency results in autistic-like phenotypes in mice. Nature 537, 675– 679 (2016). 27602517 source

      Not checked in the free run.

    • cites [41] Durak O, Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling. Nat Neurosci 19, 1477– 1488 (2016). 27694995 PMC5386887 source

      Not checked in the free run.

    • cites [42] Sakamoto I, A novel beta-catenin-binding protein inhibits beta-catenin-dependent Tcf activation and axis formation. J Biol Chem 275, 32871– 32878 (2000). 10921920 source

      Not checked in the free run.

42 of 42
  • The paper relies on this without support.

    Few ASD/ND risk genes have been studied in animal or cellular models, leaving their developmental brain function poorly defined.

    “Few of these risk genes have been studied in animal or cellular models, and thus their function during brain development remains poorly defined.”
  • The paper relies on this without support.

    Multiple ASD/ND loss-of-function risk gene mutations rarely co-occur in patients.

    “As it is rare for multiple ASD/ND loss-of-function risk gene mutations to co-occur in patients”
  • The authors state this as an assumption.

    In the linear model, module expression in individual cells is independent after conditioning on experimental batch, and noise is normally distributed.

    “Our modeling approach assumes that module expression in individual cells is independent after conditioning on the experimental batch, and that noise is normally distributed.”
  • The paper relies on this without support.

    The cellular and molecular substrates of ASD/ND are not yet defined.

    “ASD/ND affects brain function profoundly, but its cellular and molecular substrates are not yet defined.”
  • The paper relies on this without support.

    A large number of highly penetrant de novo risk genes implicated through human genetic studies provides an entry point to identify the cell types, developmental events, and mechanisms underlying ASD/ND.

    “The large number of highly penetrant de novo risk genes implicated through human genetic studies offers an entry point to identify the cell types, developmental events, and mechanisms underlying ASD/ND.”
  • The paper relies on this without support.

    Scalable methods are required to define the function of risk-associated genes with cell-type specificity.

    “However, this requires scalable methods to define the function of risk-associated genes with cell-type specificity.”
6 of 6

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Existing methods that perform perturbation-effect analysis in single-cell omics data do not achieve guaranteed confounder identification, which is a necessary condition for interpretable causal-effect estimation.

    “There are a number of existing methods that perform perturbation-effect analysis in single-cell omics data, but none of them achieve guaranteed confounder identification, which is a necessary condition for interpretable causal-effect estimation.”
  • CRISPR-Cas gene editing coupled with single-cell transcriptome readouts enables pooled genetic perturbation experiments in vivo.

    “Furthermore, CRISPR–Cas gene editing coupled with single-cell transcriptome readouts15–17 enables pooled genetic perturbation experiments in vivo18.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Cell total is unchanged after additional filtering

    Minor

    The five listed cell-class counts sum to 35,857, exactly the number said to remain after further low-quality cells were removed. The stated filtering therefore produces no reduction from the listed counts.

1 of 1

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jin, X., Simmons, S. K., Guo, A., Shetty, A. S., Ko, M., Nguyen, L., Jokhi, V., Robinson, E., Oyler, P., Curry, N., Deangeli, G., Lodato, S., Levin, J. Z., Regev, A., Zhang, F., & Arlotta, P.
Affiliations
  • Broad Institute (US)
  • Harvard University (US)
  • Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Department of Stem Cell and Regenerative Biology, Harvard University, MA, USA.
  • Humanitas University (IT)
Corresponding author
  • Jin, Xin
  • Regev, Aviv
  • Zhang, Feng
  • Arlotta, Paola
Venue
Science
Published
2020-11-27
Volume
370
Issue
6520
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W3110610967
Cited by
317
References
60
Citations by year
2026: 58 · 2025: 60 · 2024: 51 · 2023: 50 · 2022: 50 · 2021: 35 · 2020: 13
FWCI
19.89
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Science (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
Funders
  • National Institutes of Health (1R01-HG009761, 1R01-MH110049, 1DP1-HL141201, U01MH115727, R01MH096066, P50MH094271)
  • Howard Hughes Medical Institute
  • National Human Genome Research Institute
  • Brain and Behavior Research Foundation
  • Stanley Center for Psychiatric Research, Broad Institute
  • Klarman Cell Observatory, Broad Institute
  • Hock E. Tan and K. Lisa Yang Center for Autism Research at MIT
  • New York Stem Cell Foundation
  • G. Harold and Leila Y. Mathers Foundation
  • Poitras Center for Affective Disorders Research at MIT
  • Harvard William F. Milton Grant
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Keywords
autism spectrum disorder, neurodevelopmental delay, autism risk genes, mouse brain development, single-cell RNA sequencing, neuronal cell types, glial cell types
MeSH terms
Animals, Autistic Disorder, Brain, DNA-Binding Proteins, Humans, Neuroglia, Neurons, Repressor Proteins, Risk, Transcription Factors, Frameshift Mutation, Ankyrins, Gene Expression Profiling, Mice, Genetic Loci, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review